FDA warns of mold in recalled specialty drugs

NEW: FDA approves genetic test for lung cancer drug
Posted at 5:46 PM, Mar 18, 2013
and last updated 2014-06-18 11:49:57-04

WASHINGTON (AP) — The Food and Drug Administration is warning doctors and hospital managers about a nationwide recall of all drugs made by a New Jersey compounding pharmacy because they may be contaminated with mold.

The recalled products from Med Prep Consulting Inc. include dozens of drugs packaged in infusion bags, plastic syringes and glass vials distributed to regional hospitals.

The Tinton Falls, N.J.-based company said Saturday that mold was found in five bags of magnesium sulfate products dispensed to a Connecticut hospital.

No infections have been reported to date, but the FDA says it is working with officials in New Jersey and Connecticut to determine the scope of contamination.

A tainted steroid distributed by an unrelated pharmacy last year has killed 50 people and sickened more than 720 nationwide.